Recently, Nature Reviews Drug Discovery released an article titled " Top Product Forecasts for 2024 ", predicting the top 10 pharmaceutical products in 2024, all of which are projected to exceed ten billion dollars in sales
In Apr26, Axsome has entered into an asset purchase agreement with Takeda for TAK-063 (balipodect), with an intention to develop it for treating schizophrenia & Tourette syndrome (P-III study-enabling activities for schizophrenia to begin in 2026) Total Revenue: $29.44B Founded Year: 1987 Total Employees: 17,000 Headquarters: California, United States Market Cap: $176.37B Stock Exchange: NASDAQ Gilead is a global biopharma company focused on antivirals and specialty therapeutics, with leadership in HIV, oncology, and liver diseases anchored by a strong antiviral franchise and an expanding oncology portfolio
Biosimilars will for sure play a role, but obesity will be like a platform race now
GLP-1 enhances satiety, making it easier to adhere to a healthy eating plan
166108-71-0, Fmoc-NH-PEG2-CH2COOH CAS No
Engage in regular physical activity, which stimulates intestinal motility
